New Insights on the Activity and Selectivity of MAO-B Inhibitors through In Silico Methods

To facilitate the identification of novel MAO-B inhibitors, we elaborated a consolidated computational approach, including a pharmacophoric atom-based 3D quantitative structure–activity relationship (QSAR) model, activity cliffs, fingerprint, and molecular docking analysis on a dataset of 126 molecu...

Full description

Bibliographic Details
Main Authors: Liliana Pacureanu, Alina Bora, Luminita Crisan
Format: Article
Language:English
Published: MDPI AG 2023-05-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/24/11/9583
_version_ 1797597358662352896
author Liliana Pacureanu
Alina Bora
Luminita Crisan
author_facet Liliana Pacureanu
Alina Bora
Luminita Crisan
author_sort Liliana Pacureanu
collection DOAJ
description To facilitate the identification of novel MAO-B inhibitors, we elaborated a consolidated computational approach, including a pharmacophoric atom-based 3D quantitative structure–activity relationship (QSAR) model, activity cliffs, fingerprint, and molecular docking analysis on a dataset of 126 molecules. An AAHR.2 hypothesis with two hydrogen bond acceptors (A), one hydrophobic (H), and one aromatic ring (R) supplied a statistically significant 3D QSAR model reflected by the parameters: R<sup>2</sup> = 0.900 (training set); Q<sup>2</sup> = 0.774 and Pearson’s R = 0.884 (test set), stability s = 0.736. Hydrophobic and electron-withdrawing fields portrayed the relationships between structural characteristics and inhibitory activity. The quinolin-2-one scaffold has a key role in selectivity towards MAO-B with an AUC of 0.962, as retrieved by ECFP4 analysis. Two activity cliffs showing meaningful potency variation in the MAO-B chemical space were observed. The docking study revealed interactions with crucial residues TYR:435, TYR:326, CYS:172, and GLN:206 responsible for MAO-B activity. Molecular docking is in consensus with and complementary to pharmacophoric 3D QSAR, ECFP4, and MM-GBSA analysis. The computational scenario provided here will assist chemists in quickly designing and predicting new potent and selective candidates as MAO-B inhibitors for MAO-B-driven diseases. This approach can also be used to identify MAO-B inhibitors from other libraries or screen top molecules for other targets involved in suitable diseases.
first_indexed 2024-03-11T03:05:06Z
format Article
id doaj.art-e266b7c369fc41efabcafaf5be22f9c3
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-11T03:05:06Z
publishDate 2023-05-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-e266b7c369fc41efabcafaf5be22f9c32023-11-18T08:01:06ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672023-05-012411958310.3390/ijms24119583New Insights on the Activity and Selectivity of MAO-B Inhibitors through In Silico MethodsLiliana Pacureanu0Alina Bora1Luminita Crisan2“Coriolan Dragulescu” Institute of Chemistry, 24 Mihai Viteazu Ave., 300223 Timisoara, Romania“Coriolan Dragulescu” Institute of Chemistry, 24 Mihai Viteazu Ave., 300223 Timisoara, Romania“Coriolan Dragulescu” Institute of Chemistry, 24 Mihai Viteazu Ave., 300223 Timisoara, RomaniaTo facilitate the identification of novel MAO-B inhibitors, we elaborated a consolidated computational approach, including a pharmacophoric atom-based 3D quantitative structure–activity relationship (QSAR) model, activity cliffs, fingerprint, and molecular docking analysis on a dataset of 126 molecules. An AAHR.2 hypothesis with two hydrogen bond acceptors (A), one hydrophobic (H), and one aromatic ring (R) supplied a statistically significant 3D QSAR model reflected by the parameters: R<sup>2</sup> = 0.900 (training set); Q<sup>2</sup> = 0.774 and Pearson’s R = 0.884 (test set), stability s = 0.736. Hydrophobic and electron-withdrawing fields portrayed the relationships between structural characteristics and inhibitory activity. The quinolin-2-one scaffold has a key role in selectivity towards MAO-B with an AUC of 0.962, as retrieved by ECFP4 analysis. Two activity cliffs showing meaningful potency variation in the MAO-B chemical space were observed. The docking study revealed interactions with crucial residues TYR:435, TYR:326, CYS:172, and GLN:206 responsible for MAO-B activity. Molecular docking is in consensus with and complementary to pharmacophoric 3D QSAR, ECFP4, and MM-GBSA analysis. The computational scenario provided here will assist chemists in quickly designing and predicting new potent and selective candidates as MAO-B inhibitors for MAO-B-driven diseases. This approach can also be used to identify MAO-B inhibitors from other libraries or screen top molecules for other targets involved in suitable diseases.https://www.mdpi.com/1422-0067/24/11/9583monoamine oxidase Bselectivityactivity cliffECFP4
spellingShingle Liliana Pacureanu
Alina Bora
Luminita Crisan
New Insights on the Activity and Selectivity of MAO-B Inhibitors through In Silico Methods
International Journal of Molecular Sciences
monoamine oxidase B
selectivity
activity cliff
ECFP4
title New Insights on the Activity and Selectivity of MAO-B Inhibitors through In Silico Methods
title_full New Insights on the Activity and Selectivity of MAO-B Inhibitors through In Silico Methods
title_fullStr New Insights on the Activity and Selectivity of MAO-B Inhibitors through In Silico Methods
title_full_unstemmed New Insights on the Activity and Selectivity of MAO-B Inhibitors through In Silico Methods
title_short New Insights on the Activity and Selectivity of MAO-B Inhibitors through In Silico Methods
title_sort new insights on the activity and selectivity of mao b inhibitors through in silico methods
topic monoamine oxidase B
selectivity
activity cliff
ECFP4
url https://www.mdpi.com/1422-0067/24/11/9583
work_keys_str_mv AT lilianapacureanu newinsightsontheactivityandselectivityofmaobinhibitorsthroughinsilicomethods
AT alinabora newinsightsontheactivityandselectivityofmaobinhibitorsthroughinsilicomethods
AT luminitacrisan newinsightsontheactivityandselectivityofmaobinhibitorsthroughinsilicomethods